Albemarle (ALB) Q1 2026 earnings summary

Executive summary

• Net sales for Q1 2026 reached $1.43 billion, up 33% year-over-year, driven by higher pricing and volumes in Energy Storage and Specialties.

• Adjusted EBITDA rose 148% year-over-year to $664 million, reflecting strong segment performance and cost improvements.

• Net income attributable to shareholders was $319 million, with adjusted diluted EPS of $2.95.

• Divestitures of Ketjen and Eurecat JV generated $648 million in net cash proceeds, enabling $1.3 billion in debt repayment and reducing interest expense.

• Achieved $40 million in cost and productivity improvements, on track for $100–$150 million full-year target.

Financial highlights

• Adjusted EBITDA margin improved to 46.5% from 25% year-over-year.

• Diluted EPS was $2.34 for the quarter; adjusted diluted EPS was $2.95.

• Operating cash flow was $346 million and free cash flow $248 million in Q1.

• Capital expenditures totaled $99 million in Q1; full-year CapEx expected at $550–$600 million.

• Net income attributable to shareholders was $319 million, up $277.7 million year-over-year.

Outlook and guidance

• 2026 net sales guidance ranges from $4.1–$7.8 billion, with adjusted EBITDA outlook of $0.9–$4.4 billion depending on lithium price scenarios.

• Specialties segment net sales outlook raised to $1.3–$1.5 billion, with adjusted EBITDA of $225–$275 million.

• Full-year cost and productivity improvements targeted at $100–$150 million, with $40 million achieved year-to-date.

• Interest and financing expense outlook reduced to $120–$140 million for FY 2026.

• Capital expenditures forecasted at $550–$600 million for 2026.